Novartis (NYSE:NVS) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.03, beating the consensus estimate of $2.00 by $0.03 per share. Revenue came in at $13.3B, missing the estimate of $13.9B.
Novartis's stock moved following the earnings release. The stock currently trades at $153.77 with a market capitalization of $259.0B.